Target intelligence / Profile preview

ZNF687 antisense RNA 1 (ZNF687-AS1)

Target
ZNF687-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Other
01

Overview

ZNF687 antisense RNA 1 (ZNF687-AS1) is a long noncoding antisense RNA transcribed opposite the *ZNF687* gene. Antisense RNAs typically regulate the expression of neighboring or overlapping genes via diverse mechanisms, including transcriptional interference, recruitment of epigenetic modifiers, promotion of RNA degradation, or stabilization of gene transcripts[1]. While *ZNF687* itself is a zinc finger protein directly implicated in bone remodeling and cancer[3], the specific biological functions and clinical relevance of ZNF687-AS1 remain unexplored in peer-reviewed biomedical literature. General models of antisense RNA suggest potential roles in epigenetic regulation and gene expression, but ZNF687-AS1 has not been characterized as a direct therapeutic target, clinical biomarker, or drug interaction site as of the current state of research[1]. Limitations: No peer-reviewed studies or databases specifically characterize ZNF687-AS1 in terms of function, disease association, or therapeutic relevance. The structural and regulatory properties described here are inferred from general lncRNA and antisense RNA biology, and from the role of its sense gene *ZNF687*[1][3]. If more targeted research becomes available, these categories could be updated for structured annotation.

Other names
ZNF687-AS1ZNF687 antisense RNA 1
02

Mechanism of action

None known

03

Biological functions

Regulation of gene expression (likely regulates ZNF687 via transcriptional interference, chromatin remodeling, or RNA stability)Other (role hypothetical; not formally characterized)
04

Disease associations

Cancer (since *ZNF687* is oncogenic[3])Bone disease/Paget’s disease (since *ZNF687* mutations cause severe Paget’s disease[3])Other (potential roles remain speculative)

Beyond the preview

Go deeper on ZNF687 antisense RNA 1 (ZNF687-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF687 antisense RNA 1 (ZNF687-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call